These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2421731)

  • 21. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
    Pranzatelli MR; Rubin G; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Model of central chemical 'serotoninectomy' in mice.
    Herman ZS; Bonczek A
    Pharmacology; 1978; 17(1):8-14. PubMed ID: 684075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine.
    Mueller RA; Towle A; Breese GR
    Pharmacol Biochem Behav; 1985 Feb; 22(2):221-5. PubMed ID: 2580321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal effects of intrahypothalamic 5,7-dihydroxytryptamine: relationship between serotonin levels and [3H]serotonin binding.
    Frankfurt M; Allen DL; Luine VN; Beaudet A
    Brain Res; 1987 Sep; 419(1-2):216-22. PubMed ID: 2445421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased sensitivity to intracerebroventricular infusion of serotonin and deaminated indoles after lesioning rat with dihydroxytryptamine.
    Warbritton JD; Stewart RM; Baldessarini RJ
    Brain Res; 1980 Feb; 183(2):355-66. PubMed ID: 6153283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective destruction of the serotonergic fibers of the fornix-fimbria and cingulum bundle increases 5-HT1 but not 5-HT2 receptors in rat midbrain.
    Quik M; Azmitia E
    Eur J Pharmacol; 1983 Jun; 90(4):377-84. PubMed ID: 6884427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of p-chloroamphetamine and 5,7-dihydroxytryptamine on rotation and dopamine turnover.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Jun; 149(2):453-67. PubMed ID: 566608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of footshock-induced analgesia by spinal 5,7-dihydroxytryptamine lesions.
    Hutson PH; Tricklebank MD; Curzon G
    Brain Res; 1982 Apr; 237(2):367-72. PubMed ID: 7083000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective destruction of midbrain raphe nuclei by 5,7-DHT: is brain 5-HT involved in alcohol drinking in Sprague-Dawley rats?
    Adell A; Myers RD
    Brain Res; 1995 Sep; 693(1-2):70-9. PubMed ID: 8653423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure to produce blood pressure changes following pharmacological or surgical depletion of brain serotonin in the spontaneously hypertensive rat.
    Browning RA; Bramlet DG; Myers JH; Bundman MC; Smith ML
    Clin Exp Hypertens (1978); 1981; 3(5):953-73. PubMed ID: 6456876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supersensitivity of 5,7-dihydroxytryptamine-treated rats to the respiratory depressant and antitussive effects of dihydrocodeine.
    Kamei J; Ogawa M; Kasuya Y
    Eur J Pharmacol; 1988 Aug; 153(2-3):305-8. PubMed ID: 3181291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Injection of 5,7-dihydroxytryptamine into the B3 raphe region of neonatal rat pups induces hyperalgesia but only slight alterations in ingestion-related behaviors.
    Enters EK; Specht SM; Spear LP
    Behav Neural Biol; 1990 Mar; 53(2):244-57. PubMed ID: 1691912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
    Black RS; Robinson RG
    Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of 5,7-dihydroxytryptamine on the serum corticosterone resistance to suppression by dexamethasone.
    McIntyre IM; Oxenkrug GF; Stanley M; Gershon S
    Brain Res; 1984 Aug; 309(1):156-8. PubMed ID: 6488005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of serotonergic innervation from raphe nuclei in rat cerebral blood vessels--II. Lack of tryptophan hydroxylase activity in vitro.
    Mathiau P; Reynier-Rebuffel AM; Issertial O; Callebert J; Decreme C; Aubineau P
    Neuroscience; 1993 Feb; 52(3):657-65. PubMed ID: 7680792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circadian tryptophan hydroxylase levels and serotonin release in the suprachiasmatic nucleus of the rat.
    Barassin S; Raison S; Saboureau M; Bienvenu C; Maître M; Malan A; Pévet P
    Eur J Neurosci; 2002 Mar; 15(5):833-40. PubMed ID: 11906525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
    Pranzatelli MR; Huang YY; Dollison AM; Stanley M
    Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of intracerebroventricular 5,7-dihydroxytryptamine on morphine analgesia is time-dependent.
    Romandini S; Pich EM; Esposito E; Kruszewska AZ; Samanin R
    Life Sci; 1986 Mar; 38(10):869-75. PubMed ID: 3951313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developmental plasticity of central serotonin neurons after 5,7-dihydroxytryptamine treatment.
    Jonsson G; Pollare T; Hallman H; Sachs C
    Ann N Y Acad Sci; 1978 Jun; 305():328-45. PubMed ID: 280250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PHysical exercise: evidence for differential consequences of tryptophan on 5-HT synthesis and metabolism in central serotonergic cell bodies and terminals.
    Chaouloff F; Laude D; Elghozi JL
    J Neural Transm; 1989; 78(2):121-30. PubMed ID: 2478662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.